| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | | Sold All | -24,600 | -100 % | | | | -2.20 % | $738 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | | Sold All | -125,611 | -100 % | | | | -5.00 % | $8,793 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 700 | Sold Some | -300 | -30.00 % | $980 | $931 | $-49 | -5.00 % | $21 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Management Llc | No Data | | Sold All | -277,256 | -100 % | | | | -8.27 % | $33,271 | | | | | | News Article | History of Bam Management Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bvf Inc Il | Institution | | Sold All | -2,572,900 | -100 % | | | | -8.27 % | $308,748 | | | | | | News Article | History of Bvf Inc Il Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 3,209 | Sold Some | -5,927 | -64.87 % | $4,653 | $4,268 | $-385 | -8.27 % | $711 | | | | | | News Article | History of Citadel L P Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 2,000 | No Change | 0 | 0 % | $2,900 | $2,660 | $-240 | -8.27 % | $0 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 3,279,506 | Sold Some | -340,800 | -9.41 % | $4,755,284 | $4,361,743 | $-393,541 | -8.27 % | $40,896 | | | | | | News Article | History of Fmr Corp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 673,775 | New Holding | 673,775 | 100 % | $976,974 | $896,121 | $-80,853 | -8.27 % | $-80,853 | | | | | | News Article | History of Millennium Management Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 20,885 | Sold Some | -64,433 | -75.52 % | $30,283 | $27,777 | $-2,506 | -8.27 % | $7,732 | | | | | | News Article | History of Morgan Stanley Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 132,639 | Sold Some | -150,334 | -53.12 % | $192,327 | $176,410 | $-15,917 | -8.27 % | $18,040 | | | | | | News Article | History of Northern Trust Corp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 5,200,714 | Added More | 1,489,838 | 40.14 % | $7,541,035 | $6,916,950 | $-624,086 | -8.27 % | $-178,781 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wexford Capital Llc | Institution | 13,400 | New Holding | 13,400 | 100 % | $19,430 | $17,822 | $-1,608 | -8.27 % | $-1,608 | | | | | | News Article | History of Wexford Capital Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 74,309 | New Holding | 74,309 | 100 % | $107,748 | $98,831 | $-8,917 | -8.27 % | $-8,917 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 68,042 | Sold Some | -143,082 | -67.77 % | $98,661 | $90,496 | $-8,165 | -8.27 % | $17,170 | | | | | | News Article | History of Barclays Plc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | | Sold All | -1,370,820 | -100 % | | | | -8.27 % | $164,498 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | | Sold All | -14,400 | -100 % | | | | -8.27 % | $1,728 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 136,690 | Added More | 66,915 | 95.90 % | $198,201 | $181,798 | $-16,403 | -8.27 % | $-8,030 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 48,580 | Sold Some | -255,329 | -84.01 % | $70,441 | $64,611 | $-5,830 | -8.27 % | $30,639 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | | Sold All | -1,052,468 | -100 % | | | | -8.27 % | $126,296 | | | | | | News Article | History of Hambrecht And Quist Capital Management Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jefferies Group Inc | Institution | | Sold All | -19,100 | -100 % | | | | -8.27 % | $2,292 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | 347,786 | Added More | 288,937 | 490.98 % | $504,290 | $462,555 | $-41,734 | -8.27 % | $-34,672 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | | Sold All | -3,054,200 | -100 % | | | | -8.27 % | $366,504 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Inc | Institution | 700 | No Change | 0 | 0 % | $1,015 | $931 | $-84 | -8.27 % | $0 | | | | | | News Article | History of Rbc Private Counsel Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 226,018 | Added More | 207,818 | 1141.85 % | $327,726 | $300,604 | $-27,122 | -8.27 % | $-24,938 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Spark Lp | Institution | 194,400 | New Holding | 194,400 | 100 % | $281,880 | $258,552 | $-23,328 | -8.27 % | $-23,328 | | | | | | News Article | History of Spark Lp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 757,416 | Added More | 342,050 | 82.34 % | $1,098,253 | $1,007,363 | $-90,890 | -8.27 % | $-41,046 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | | Sold All | -69,600 | -100 % | | | | -4.31 % | $4,176 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 517,757 | Sold Some | -1,454 | -0.28 % | $719,682 | $688,617 | $-31,065 | -4.31 % | $87 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 10,000 | New Holding | 10,000 | 100 % | $13,900 | $13,300 | $-600 | -4.31 % | $-600 | | | | | | News Article | History of Credit Suisse Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 87 | New Holding | 87 | 100 % | $121 | $116 | $-5 | -4.31 % | $-5 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 195,000 | New Holding | 195,000 | 100 % | $271,050 | $259,350 | $-11,700 | -4.31 % | $-11,700 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 51,621 | Sold Some | -76,479 | -59.70 % | $71,753 | $68,656 | $-3,097 | -4.31 % | $4,589 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | 199,957 | New Holding | 199,957 | 100 % | $277,940 | $265,943 | $-11,997 | -4.31 % | $-11,997 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | | Sold All | -3,359,373 | -100 % | | | | -15.82 % | $839,843 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | | Sold All | -4,800 | -100 % | | | | -15.82 % | $1,200 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 131,950 | Added More | 92,720 | 236.34 % | $208,481 | $175,494 | $-32,988 | -15.82 % | $-23,180 | | | | | | News Article | History of Ubs Ag Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 11,363 | New Holding | 11,363 | 100 % | $15,795 | $15,113 | $-682 | -4.31 % | $-682 | | | | | | News Article | History of Federated Investors Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 141,400 | New Holding | 141,400 | 100 % | $196,546 | $188,062 | $-8,484 | -4.31 % | $-8,484 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metlife Securities Inc | Institution | 30,700 | New Holding | 30,700 | 100 % | $40,831 | $40,831 | $0 | 0.00 % | $0 | | | | | | News Article | History of Metlife Securities Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 1,400 | No Change | 0 | 0 % | $1,862 | $1,862 | $0 | 0.00 % | $0 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Dowling And Yahnke Inc | Institution | 10,000 | No Change | 0 | 0 % | $13,100 | $13,300 | $200 | 1.52 % | $0 | | | | | | News Article | History of Dowling And Yahnke Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 620,788 | Sold Some | -30,800 | -4.72 % | $813,232 | $825,648 | $12,416 | 1.52 % | $-616 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | | Sold All | -147,514 | -100 % | | | | 2.30 % | $-4,425 | | | | | | News Article | History of Oxford Asset Management Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 2,295 | No Compare | | | $2,984 | $3,052 | $69 | 2.30 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Mercantile Funds Inc - Mercantile Capital Opportunities Fund | Specialty & Misc | | Sold All | -23,566 | -100 % | | | | 2.30 % | $-707 | | | | | | News Article | History of Mercantile Funds Inc - Mercantile Capital Opportunities Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 811,846 | Added More | 90,100 | 12.48 % | $1,104,111 | $1,079,755 | $-24,355 | -2.20 % | $-2,703 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Riversource Managers Series Inc - Riversource Fundamental Value Fund | Multi-Cap Core | 6,421 | New Holding | 6,421 | 100 % | $8,733 | $8,540 | $-193 | -2.20 % | $-193 | | | | | | News Article | History of Riversource Managers Series Inc - Riversource Fundamental Value Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -1,900 | -100 % | | | | -2.20 % | $57 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 49,000 | New Holding | 49,000 | 100 % | $66,640 | $65,170 | $-1,470 | -2.20 % | $-1,470 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Fund | Small-Cap Core | 4,600 | New Holding | 4,600 | 100 % | $6,256 | $6,118 | $-138 | -2.20 % | $-138 | | | | | | News Article | History of Valic Co I - Small Cap Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 4,500 | Sold Some | -8,520 | -65.43 % | $7,290 | $5,985 | $-1,305 | -17.90 % | $2,471 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 52,011 | Sold Some | -1,450 | -2.71 % | $86,338 | $69,175 | $-17,164 | -19.87 % | $479 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 23,400 | Added More | 2,300 | 10.90 % | $38,610 | $31,122 | $-7,488 | -19.39 % | $-736 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Nordea Investment Management Ab | Institution | 288,000 | Added More | 76,800 | 36.36 % | $524,160 | $383,040 | $-141,120 | -26.92 % | $-37,632 | | | | | | News Article | History of Nordea Investment Management Ab Ownership Of Acadia Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 57,748 | Added More | 28,874 | 100.00 % | $105,101 | $76,805 | $-28,297 | -26.92 % | $-14,148 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Delaware Pooled Trust Inc - Delaware Reit Fund | Real Estate | | Sold All | -1,400 | -100 % | | | | -23.12 % | $560 | | | | | | News Article | History of Delaware Pooled Trust Inc - Delaware Reit Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 34,324 | Added More | 3,792 | 12.41 % | $59,381 | $45,651 | $-13,730 | -23.12 % | $-1,517 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 5,108 | New Holding | 5,108 | 100 % | $8,837 | $6,794 | $-2,043 | -23.12 % | $-2,043 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Va Small Value Portfolio | Small-Cap Value | 449,860 | Sold Some | -3,174 | -0.70 % | $778,258 | $598,314 | $-179,944 | -23.12 % | $1,270 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Va Small Value Portfolio Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | | Sold All | -536 | -100 % | | | | -23.12 % | $214 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Seligman Global Fund Series Inc - Global Smaller Companies Fund | Global Small/Mid-Cap Core | 61,500 | New Holding | 61,500 | 100 % | $106,395 | $81,795 | $-24,600 | -23.12 % | $-24,600 | | | | | | News Article | History of Seligman Global Fund Series Inc - Global Smaller Companies Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 8,444 | New Holding | 8,444 | 100 % | $15,199 | $11,231 | $-3,969 | -26.11 % | $-3,969 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-17 | 2009-06-30 | 13F-HR/A | Delaware Management Business Trust | Institution | 1,370,820 | Sold Some | -432,762 | -23.99 % | $2,631,974 | $1,823,191 | $-808,784 | -30.72 % | $255,330 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 519,211 | Sold Some | -1,238,865 | -70.46 % | $1,002,077 | $690,551 | $-311,527 | -31.08 % | $743,319 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | | Sold All | -1,064 | -100 % | | | | -32.48 % | $681 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | | Sold All | -253 | -100 % | | | | -32.48 % | $162 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -24,700 | -100 % | | | | -34.48 % | $17,290 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | | Sold All | -24,800 | -100 % | | | | -34.48 % | $17,360 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 110,968 | New Holding | 110,968 | 100 % | $225,265 | $147,587 | $-77,678 | -34.48 % | $-77,678 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 3,620,306 | Sold Some | -520,000 | -12.55 % | $7,240,612 | $4,815,007 | $-2,425,605 | -33.50 % | $348,400 | | | | | | News Article | History of Fmr Corp Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | | Sold All | -300 | -100 % | | | | -77.22 % | $1,353 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | | Sold All | -359,036 | -100 % | | | | -77.75 % | $1,669,517 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | | Sold All | -226,634 | -100 % | | | | -77.75 % | $1,053,848 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | | Sold All | -404,739 | -100 % | | | | -77.75 % | $1,882,036 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | | Sold All | -1,876 | -100 % | | | | -77.75 % | $8,723 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | | Sold All | -7,758 | -100 % | | | | -77.75 % | $36,075 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 49,645 | Added More | 4,271 | 9.41 % | $296,877 | $66,028 | $-230,849 | -77.75 % | $-19,860 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 1,000 | Added More | 700 | 233.33 % | $5,980 | $1,330 | $-4,650 | -77.75 % | $-3,255 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | | Sold All | -8,562 | -100 % | | | | -78.01 % | $40,413 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -8,615 | -100 % | | | | -78.01 % | $40,663 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 263,583 | New Holding | 263,583 | 100 % | $1,594,677 | $350,565 | $-1,244,112 | -78.01 % | $-1,244,112 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 22,275 | New Holding | 22,275 | 100 % | $134,764 | $29,626 | $-105,138 | -78.01 % | $-105,138 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 15,540 | No Change | 0 | 0 % | $94,017 | $20,668 | $-73,349 | -78.01 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Jefferies Group Inc | Institution | 19,100 | New Holding | 19,100 | 100 % | $115,364 | $25,403 | $-89,961 | -77.98 % | $-89,961 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Acadia Pharmaceuticals Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |
RSS feed for ACAD